CHE Chemed Corp

$434.42▼ -2.65% Unknown Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$5.77B
P/E Ratio
23.7
Div Yield
0.54%
52W Range
365.21 - 562.77
% vs 50 MA
8.08%
% vs 200 MA
3.57%
RSI-14
63.7
MACD Histogram
-0.2300
Beta (1Y vs SPY)
0.22
Free Cash Flow
$71.10M
Gross Rev
$657.51M
Gross Profit
$215.76M
EBITDA
$102.34M
COGS
$441.75M
Operating Exp
$131.19M
Operating Income
$84.58M
EBIT
$84.58M
Pretax Income
$88.84M
Net Income
$66.30M
EPS (Diluted)
4.84
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
Social Sentiment
No Reddit posts found for CHE.
AI Analysis
Generated May 28, 10:10 PM
Company Overview

Chemed Corporation operates two distinct, wholly-owned subsidiaries: VITAS Healthcare, the largest provider of hospice and palliative care services in the U.S., and Roto-Rooter, the largest provider of plumbing, drain cleaning, and water cleanup services in North America. This unique structure provides diversification across essential services, balancing healthcare with home maintenance.

Bull Case
  • The diversified business model, combining stable hospice care with resilient home services, offers revenue stability and reduces single-market dependency.
  • VITAS Healthcare benefits from favorable demographic trends, with an aging U.S. population driving increasing demand for end-of-life care services.
  • Roto-Rooter's services are largely non-discretionary and recession-resistant, providing consistent cash flow and a strong brand presence in a fragmented market.
  • Both subsidiaries hold leading market positions in their respective industries, suggesting competitive advantages and potential for continued market share growth.
Bear Case
  • VITAS Healthcare is highly susceptible to regulatory changes, reimbursement policy shifts, and government scrutiny, which can impact profitability and operational flexibility.
  • Both segments face potential challenges from rising labor costs and shortages, particularly for skilled healthcare professionals and plumbers, which could pressure margins.
  • The disparate nature of the two businesses (healthcare vs. home services) may limit operational synergies and create complexities in management and strategic focus.
  • The stock is trading 24.0% below its 52-week high, indicating a significant correction or lingering investor concerns that could cap near-term upside.
Recent Performance

CHE has shown positive momentum recently, trading 8.7% above its 50-day moving average and 1.3% above its 200-day moving average, indicating a constructive short-to-medium term trend. Despite this recovery, the stock remains 24.0% off its 52-week high, suggesting it's still in a rebound phase from a prior downturn. The RSI of 65.1 points to strong buying interest but is approaching levels that could signal overbought conditions, potentially leading to consolidation.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙